Ha Y. Mo
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Regional bias of tumor suppressor gene mutations of STARD8 and WNK2 in colon cancers.
Journal: Pathology, research and practice
Published: November 03, 2023
Genes with dual proto-oncogene and tumor suppressor gene activities are frequently altered by protein losses in colon cancers.
Journal: Pathology, research and practice
Published: April 26, 2023
Concurrent inactivating mutations and expression losses of RGS2, HNF1A, and CAPN12 candidate tumor suppressor genes in colon cancers.
Journal: Pathology, research and practice
Published: November 17, 2022
Mutational Alterations of DNA Methylation-related Genes CTCF, ZFP57, and ATF7IP Genes in Colon Cancers.
Journal: Applied immunohistochemistry & molecular morphology : AIMM
Published: April 20, 2021
Mutation and expression alterations of histone methylation-related NSD2, KDM2B and SETMAR genes in colon cancers.
Journal: Pathology, research and practice
Published: December 23, 2020
Cancer-related SRCAP and TPR mutations in colon cancers.
Journal: Pathology, research and practice
Published: October 16, 2020
Somatic Mutation of NLRP Genes in Gastric and Colonic Cancers.
Journal: Pathology oncology research : POR
Published: September 17, 2020
Frameshift Mutations and Loss of Expression of CLCA4 Gene are Frequent in Colorectal Cancers With Microsatellite Instability.
Journal: Applied immunohistochemistry & molecular morphology : AIMM
Published: August 11, 2020
Somatic mutations of cancer-related genes PELP1 and BDP1 in colorectal cancers.
Journal: Pathology, research and practice
Published: May 12, 2020
Mutational alterations of TDRD 1, 4 and 9 genes in colorectal cancers.
Journal: Pathology oncology research : POR
Published: December 24, 2019
Inactivating mutations of tumor suppressor genes ABCA1 and CAPN13 in colorectal cancers.
Journal: Pathology, research and practice
Published: December 23, 2019
Decreased protein expression of candidate tumor suppressors TET3 and EPB41L3 in prostate cancers.
Journal: Pathology, research and practice
Published: October 11, 2019
Last Updated: 09/26/2026